Table of Contents
ISRN Neurology
Volume 2013, Article ID 981070, 6 pages
http://dx.doi.org/10.1155/2013/981070
Clinical Study

Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels

Department of Neurology, Eginition Hospital, Athens University Medical School, Vassilissis Sophias 74, 11528 Athens, Greece

Received 11 July 2013; Accepted 19 August 2013

Academic Editors: D. Mathieu, T. Mezaki, D. Schiffer, and E. M. Wassermann

Copyright © 2013 Manolis Markianos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Marrie and R. I. Horwitz, “Emerging effects of comorbidities on multiple sclerosis,” Lancet Neurology, vol. 9, no. 8, pp. 820–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. L. Esparza, S. Sasaki, and H. Kesteloot, “Nutrition, latitude, and multiple sclerosis mortality: an ecologic study,” American Journal of Epidemiology, vol. 142, no. 7, pp. 733–737, 1995. View at Google Scholar · View at Scopus
  3. P. Ghadirian, M. Jain, S. Ducic, B. Shatenstein, and R. Morisset, “Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada,” International Journal of Epidemiology, vol. 27, no. 5, pp. 845–852, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Habek, I. Hojsak, and V. V. Brinar, “Nutrition in multiple sclerosis,” Clinical Neurology and Neurosurgery, vol. 112, no. 7, pp. 616–620, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Schwarz and H. Leweling, “Multiple sclerosis and nutrition,” Multiple Sclerosis, vol. 11, no. 1, pp. 24–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Riccio, R. Rossano, and G. M. Liuzzi, “May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach,” Autoimmune Diseases, vol. 2010, Article ID 249842, 12 pages, 2010. View at Publisher · View at Google Scholar
  7. C. A. Formica, F. Cosman, J. Nieves, J. Herbert, and R. Lindsay, “Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use,” Calcified Tissue International, vol. 61, no. 2, pp. 129–133, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. M. W. Nortvedt, T. Riise, and J. G. Mæland, “Multiple sclerosis and lifestyle factors: the Hordaland Health Study,” Neurological Sciences, vol. 26, no. 5, pp. 334–339, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. N. Alschuler, L. E. Gibbons, D. E. Rosenberg et al., “Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury,” Disability and Health Journal, vol. 5, no. 3, pp. 177–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. R. Khurana, A. M. Bamer, A. P. Turner et al., “The prevalence of overweight and obesity in veterans with multiple sclerosis,” American Journal of Physical Medicine and Rehabilitation, vol. 88, no. 2, pp. 83–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Pike, E. Jones, K. Rajagopalan, J. Piercy, and P. Anderson, “Social and economic burden of walking and mobility problems in multiple sclerosis,” BMC Neurology, vol. 12, article 94, 2012. View at Google Scholar
  12. K. L. Munger, T. Chitnis, and A. Ascherio, “Body size and risk of MS in two cohorts of US women,” Neurology, vol. 73, no. 19, pp. 1543–1550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. K. Hedstrom, T. Olsson, and L. Alfredsson, “High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women,” Multiple Sclerosis, vol. 18, pp. 1334–1336, 2012. View at Google Scholar
  14. M. W. Schwartz, S. C. Woods, D. Porte Jr., R. J. Seeley, and D. G. Baskin, “Central nervous system control of food intake,” Nature, vol. 404, no. 6778, pp. 661–671, 2000. View at Google Scholar · View at Scopus
  15. R. D. Palmiter, “Is dopamine a physiologically relevant mediator of feeding behavior?” Trends in Neurosciences, vol. 30, no. 8, pp. 375–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Q.-Y. Zhou and R. D. Palmiter, “Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic,” Cell, vol. 83, no. 7, pp. 1197–1209, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Szczypka, M. A. Rainey, and R. D. Palmiter, “Dopamine is required for hyperphagia in Lep(ob/ob) mice,” Nature Genetics, vol. 25, no. 1, pp. 102–104, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Wise, “Role of brain dopamine in food reward and reinforcement,” Philosophical Transactions of the Royal Society B, vol. 361, no. 1471, pp. 1149–1158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Markianos, M.-E. Evangelopoulos, G. Koutsis, and C. Sfagos, “Elevated CSF serotonin and dopamine metabolite levels in overweight subjects,” Obesity, vol. 21, pp. 1139–1142, 2013. View at Google Scholar
  20. M. Markianos, G. Koutsis, M.-E. Evangelopoulos, D. Mandellos, G. Karahalios, and C. Sfagos, “Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis,” Journal of Neurochemistry, vol. 108, no. 1, pp. 158–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. H. Polman, S. C. Reingold, G. Edan et al., “Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”,” Annals of Neurology, vol. 58, no. 6, pp. 840–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Wetterling, “Bodyweight gain with atypical antipsychotics: a comparative review,” Drug Safety, vol. 24, no. 1, pp. 59–73, 2001. View at Google Scholar · View at Scopus
  23. S.-M. Orton, B. M. Herrera, I. M. Yee et al., “Sex ratio of multiple sclerosis in Canada: a longitudinal study,” Lancet Neurology, vol. 5, no. 11, pp. 932–936, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Debouverie, “Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France,” Journal of the Neurological Sciences, vol. 286, no. 1-2, pp. 14–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Lamb, X. Yin, G. O. Zerbe et al., “Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young,” Diabetologia, vol. 52, no. 10, pp. 2064–2071, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Silventoinen, S. Sammalisto, M. Perola et al., “Heritability of adult body height: a comparative study of twin cohorts in eight countries,” Twin Research, vol. 6, no. 5, pp. 399–408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Sorva, E.-M. Tolppanen, S. Lankinen, and J. Perheentupa, “Growth evaluation: parent and child specific height standards,” Archives of Disease in Childhood, vol. 64, no. 10, pp. 1483–1487, 1989. View at Google Scholar · View at Scopus
  28. M. Stommel and C. A. Schoenborn, “Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001–2006,” BMC Public Health, vol. 9, article 421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. K. C. Berridge, C.-Y. Ho, J. M. Richard, and A. G. Difeliceantonio, “The tempted brain eats: pleasure and desire circuits in obesity and eating disorders,” Brain Research, vol. 1350, pp. 43–64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. G. S. Kranz, S. Kasper, and R. Lanzenberger, “Reward and the serotonergic system,” Neuroscience, vol. 166, no. 4, pp. 1023–1035, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. V. Considine, M. K. Sinha, M. L. Heiman et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans,” The New England Journal of Medicine, vol. 334, no. 5, pp. 292–295, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Friedman and J. L. Halaas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. J. D. Hommel, R. Trinko, R. M. Sears et al., “Leptin receptor signaling in midbrain dopamine neurons regulates feeding,” Neuron, vol. 51, no. 6, pp. 801–810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Matarese, P. B. Carrieri, A. La Cava et al., “Leptin increase in multiple sclerosis associates with reduced number of CD4+CD25+ regulatory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5150–5155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Payne, “Nutrition and diet in the clinical management of multiple sclerosis,” Journal of Human Nutrition and Dietetics, vol. 14, no. 5, pp. 349–357, 2001. View at Publisher · View at Google Scholar · View at Scopus